A genetic variant near<i>GATA3</i>implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)-Reference-Cited by-同舟云学术

A genetic variant nearGATA3implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)

Published:2017-06-28 Issue:11 Volume:77 Page:1213-1220
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Na Rong¹²³,Helfand Brian T.¹⁴,Chen Haitao⁵,Conran Carly A.¹,Crawford Susan E.¹,Hayward Simon W.¹,Tammela Teuvo L.J.⁶,Hoffman-Bolton Judy⁷,Zheng Siqun L.¹,Walsh Patrick C.⁸,Schleutker Johanna⁹,Platz Elizabeth A.⁷,Isaacs William B.⁸¹⁰,Xu Jianfeng¹²^ORCID

Affiliation:

1. Program for Personalized Cancer Care; NorthShore University HealthSystem; Evanston Illinois

2. Fudan Institute of Urology, Huashan Hospital; Fudan University; Shanghai China

3. Fudan Universtiy Shanghai Medical College; Shanghai; China

4. Department of Surgery; NorthShore University HealthSystem; Evanston Illinois

5. Fudan University School of Public Health; Shanghai; China

6. Department of Urology, Tampere University Hospital and Medical School; University of Tampere; Tampere Finland

7. Department of Epidemiology; Johns Hopkins University Bloomberg School of Public Health; Baltimore Maryland

8. Department of Urology and the James Buchanan Brady Urologic Institute; Johns Hopkins University School of Medicine; Baltimore Maryland

9. Department of Medical Biochemistry and Genetics; University of Turku; Turku Finland

10. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore Maryland

Funder

GlaxoSmithKline

National Institute of Diabetes and Digestive and Kidney Diseases

National Cancer Institute

Publisher

Wiley

Reference30 articles.

1. Epidemiology and natural history of benign prostatic hyperplasia;Barry;Urol Clin North Am,1990

2. The economics of medical therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia;Nickel;Curr Urol Rep,2006

3. The pathogenesis of benign prostatic hyperplasia;Wilson;Am J Med,1980

4. Metabolic factors associated with benign prostatic hyperplasia;Parsons;J Clin Endocrinol Metab,2006

5. PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia;Jiang;Differentiation,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cross-tissue transcriptome-wide association study identifies new susceptibility genes for benign prostatic hyperplasia;Scientific Reports;2025-01-25

2. Molecular biology, genetic, and epigenetics of prostate disease;Genetics and Epigenetics of Genitourinary Diseases;2025

3. Genetic Predisposition to Benign Prostatic Hyperplasia: Where Do We Stand?;European Urology Open Science;2024-12

4. Inheritance patterns of lower urinary tract symptoms in adults: a systematic review;BJU International;2024-08-26

5. Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis;Medicine;2024-03-01